Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning

Anticancer peptides (ACPs) are selective and toxic to cancer cells as new anticancer drugs. Identifying new ACPs is time-consuming and expensive to evaluate all candidates’ anticancer abilities. To reduce the cost of ACP drug development, we collected the most updated ACP data to train a convolution...

Full description

Bibliographic Details
Main Authors: Yih-Yun Sun, Tzu-Tang Lin, Wen-Chih Cheng, I-Hsuan Lu, Chung-Yen Lin, Shu-Hwa Chen
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/4/422
_version_ 1827599645539303424
author Yih-Yun Sun
Tzu-Tang Lin
Wen-Chih Cheng
I-Hsuan Lu
Chung-Yen Lin
Shu-Hwa Chen
author_facet Yih-Yun Sun
Tzu-Tang Lin
Wen-Chih Cheng
I-Hsuan Lu
Chung-Yen Lin
Shu-Hwa Chen
author_sort Yih-Yun Sun
collection DOAJ
description Anticancer peptides (ACPs) are selective and toxic to cancer cells as new anticancer drugs. Identifying new ACPs is time-consuming and expensive to evaluate all candidates’ anticancer abilities. To reduce the cost of ACP drug development, we collected the most updated ACP data to train a convolutional neural network (CNN) with a peptide sequence encoding method for initial in silico evaluation. Here we introduced PC6, a novel protein-encoding method, to convert a peptide sequence into a computational matrix, representing six physicochemical properties of each amino acid. By integrating data, encoding method, and deep learning model, we developed AI4ACP, a user-friendly web-based ACP distinguisher that can predict the anticancer property of query peptides and promote the discovery of peptides with anticancer activity. The experimental results demonstrate that AI4ACP in CNN, trained using the new ACP collection, outperforms the existing ACP predictors. The 5-fold cross-validation of AI4ACP with the new collection also showed that the model could perform at a stable level on high accuracy around 0.89 without overfitting. Using AI4ACP, users can easily accomplish an early-stage evaluation of unknown peptides and select potential candidates to test their anticancer activities quickly.
first_indexed 2024-03-09T04:18:57Z
format Article
id doaj.art-68648c10ca034501a63d44297d403b7a
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-09T04:18:57Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-68648c10ca034501a63d44297d403b7a2023-12-03T13:49:31ZengMDPI AGPharmaceuticals1424-82472022-03-0115442210.3390/ph15040422Peptide-Based Drug Predictions for Cancer Therapy Using Deep LearningYih-Yun Sun0Tzu-Tang Lin1Wen-Chih Cheng2I-Hsuan Lu3Chung-Yen Lin4Shu-Hwa Chen5Graduate Institute of Biomedical Electronics and Bioinformatics, College of Electrical Engineering and Computer Science, National Taiwan University, Taipei 106, TaiwanInstitute of Information Science, Academia Sinica, Taipei 115, TaiwanInstitute of Information Science, Academia Sinica, Taipei 115, TaiwanInstitute of Information Science, Academia Sinica, Taipei 115, TaiwanInstitute of Information Science, Academia Sinica, Taipei 115, TaiwanResearch Center of Cancer Translational Medicine, Taipei Medical University, Taipei 110, TaiwanAnticancer peptides (ACPs) are selective and toxic to cancer cells as new anticancer drugs. Identifying new ACPs is time-consuming and expensive to evaluate all candidates’ anticancer abilities. To reduce the cost of ACP drug development, we collected the most updated ACP data to train a convolutional neural network (CNN) with a peptide sequence encoding method for initial in silico evaluation. Here we introduced PC6, a novel protein-encoding method, to convert a peptide sequence into a computational matrix, representing six physicochemical properties of each amino acid. By integrating data, encoding method, and deep learning model, we developed AI4ACP, a user-friendly web-based ACP distinguisher that can predict the anticancer property of query peptides and promote the discovery of peptides with anticancer activity. The experimental results demonstrate that AI4ACP in CNN, trained using the new ACP collection, outperforms the existing ACP predictors. The 5-fold cross-validation of AI4ACP with the new collection also showed that the model could perform at a stable level on high accuracy around 0.89 without overfitting. Using AI4ACP, users can easily accomplish an early-stage evaluation of unknown peptides and select potential candidates to test their anticancer activities quickly.https://www.mdpi.com/1424-8247/15/4/422anticancer peptides (ACPs)deep learningweb serviceprediction
spellingShingle Yih-Yun Sun
Tzu-Tang Lin
Wen-Chih Cheng
I-Hsuan Lu
Chung-Yen Lin
Shu-Hwa Chen
Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning
Pharmaceuticals
anticancer peptides (ACPs)
deep learning
web service
prediction
title Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning
title_full Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning
title_fullStr Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning
title_full_unstemmed Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning
title_short Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning
title_sort peptide based drug predictions for cancer therapy using deep learning
topic anticancer peptides (ACPs)
deep learning
web service
prediction
url https://www.mdpi.com/1424-8247/15/4/422
work_keys_str_mv AT yihyunsun peptidebaseddrugpredictionsforcancertherapyusingdeeplearning
AT tzutanglin peptidebaseddrugpredictionsforcancertherapyusingdeeplearning
AT wenchihcheng peptidebaseddrugpredictionsforcancertherapyusingdeeplearning
AT ihsuanlu peptidebaseddrugpredictionsforcancertherapyusingdeeplearning
AT chungyenlin peptidebaseddrugpredictionsforcancertherapyusingdeeplearning
AT shuhwachen peptidebaseddrugpredictionsforcancertherapyusingdeeplearning